End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
23.17 CNY 0.00% Intraday chart for Sinocare Inc. +16.32% -23.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sinocare Inc. Proposes Final Dividend for 2023 CI
Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Sinocare Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023. CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023. CI
Sinocare Gets US FDA's Nod to Market Trueness Monitoring Device MT
Sinocare Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023. CI
Sinocare Gets EU Certificate for Continuous Glucose Monitoring System MT
Sinocare Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sinocare Inc. announces an Equity Buyback for CNY 150 million worth of its shares. CI
Sinocare Inc. authorizes a Buyback Plan. CI
Changsha Xinnuo Health Industry Investment Co., Ltd. announced that it has received CNY 496.732672 million in funding from Sinocare Inc. CI
Sinocare Registers Three Medical Devices MT
Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023 CI
Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sinocare Inc. Proposes Final Dividend for 2022 CI
Sinocare Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Changsha Xinnuo Health Industry Investment Co., Ltd. announced that it expects to receive CNY 496.732672 million in funding from Sinocare Inc. CI
Sinocare Inc. Approves Board Elections CI
Sinocare Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Sinocare Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on July 16, 2021. CI
Sinocare Inc.'s Equity Buyback announced on July 15, 2021, has expired with 6,999,287 shares, representing 1.24% for CNY 168.58 million. CI
Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on July 16, 2021. CI
Chart Sinocare Inc.
More charts
Sinocare Inc. is a China-based company principally engaged in the research, development, production and distribution of blood sugar monitoring systems. The Company mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The Company also provides diabetes management information systems. It distributes its products within domestic market and to overseas markets under the brand name of SANNUO.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
23.17 CNY
Average target price
31.01 CNY
Spread / Average Target
+33.85%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300298 Stock
  4. News Sinocare Inc.
  5. Sinocare Gets EU Certificate for Continuous Glucose Monitoring System